In men with coronary artery disease flow-mediated vasodilatation was observed after 12 weeks (61).
We thank Dr. Ellen R. Richie (University of Texas, MD Anderson Cancer Center, Science Park Research Division, Smithville, TX) and Dr. Lauren Ehrlich (University of Texas, Austin TX) for reading the manuscript, and Julie Nelson (University of Georgia, Center for Tropical and Emerging Global Diseases Flow Cytometry Facility, Athens, GA) for help with cell sorting.
A typical epidemic often involves the transmission of a disease, the flow of information regarding the disease, and the spread of human preventive behaviors against the disease.
With the development of novel technologies, more sensitive detection of residual disease using flow cytomery and next generation sequencing has been possible.
In situations where the maneuver of manual compression of the abdomen is impossible to perform or unreliable, it may be reasonable to assume that most of patients with chronic obstructive disease suffer flow limitation [18, 26].
It has been shown that in the absence of macroscopic coronary artery disease, global flow reserve can be impaired in heart failure as a consequence of microvascular dysfunction.
Risk factors considered for risk assignment were the need for two induction courses to achieve CR, detectable minimal residual disease by flow cytometry after intensification therapy (AML-03), and presence of FLT3-ITD (AML-03).
95CI: 95% confidence interval, ACE-inhibitor: angiotensin conversion enzyme, ARB: angiotensin II receptor blocker, CAD: coronary artery disease, FMD: flow mediated dilation, NS: non significant, VCAM: Vascular Cellular Adhesion Molecule.
32, 33 A study by Osto et al found that, in young patients with severe psoriasis and no heart disease, coronary flow rate was reduced, suggesting early coronary microvascular dysfunction.
Interestingly, in coronary artery disease, coronary flow reserve may not only be impaired in areas supplied by stenotic vessels, but also in those supplied by non-stenotic vessels [ 25], emphasizing the incremental value of coronary flow reserve over measurements of atherosclerosis and relative regional perfusion.
